Neptune Jinhe Pharma Accused Of Bribery, Monopoly Practices
This article was originally published in PharmAsia News
Executive Summary
A total of 98 Shandong province drug distribution companies jointly drafted a statement outlining alleged commercial bribery and monopoly practices by Shandong Neptune Jinhe Pharmaceutical